Are you Dr. Marek?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 60 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
60 Temple St
New Haven, CT 06510Phone+1 203-401-4300Fax+1 203-401-4301- Is this information wrong?
Summary
- Dr. Kenneth Marek, MD is a board certified neurologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and Maryland. He is affiliated with Yale-New Haven Hospital.
Education & Training
- Johns Hopkins UniversityResidency, Neurology, 1984 - 1986
- Johns Hopkins UniversityResidency, Internal Medicine, 1982 - 1984
- Johns Hopkins UniversityInternship, Internal Medicine, 1978 - 1979
- Yale School of MedicineClass of 1978
Certifications & Licensure
- CT State Medical License 1989 - 2024
- MD State Medical License 1985 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease Start of enrollment: 2003 May 01
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease Start of enrollment: 2005 Jan 01
- Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome Start of enrollment: 1992 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsFlortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project.Yi Su, Hillary Protas, Ji Luo, Kewei Chen, Michael L Alosco, Charles H Adler, Laura J Balcer, Charles Bernick, Rhoda Au, Sarah J Banks, William B Barr, Michael J Colem...> ;Alzheimer's & Dementia. 2024 Mar 1
- 12 citationsA biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.Simuni, T., Chahine, L., Poston, K., Brumm, M., Buracchio, T., Campbell, M., Chowdhury, S., Coffey, C., Concha-Marambio, L., Dam, T., DiBiaso, P., Foroud, T., Frasier,...> ;The Lancet. Neurology. 2024 Feb 1
- 4 citationsNeuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease.Shijun Yan, Cheng Jiang, Annette Janzen, Thomas R Barber, Aline Seger, Michael Sommerauer, Jason J Davis, Kenneth Marek, Michele T Hu, Wolfgang H Oertel, George K Tofaris> ;JAMA Neurology. 2024 Jan 1
- Join now to see all
Press Mentions
- Michael J. Fox Foundation Discovers Breakthrough in Search for Parkinson’s BiomarkerApril 17th, 2023
- Parkinson’s Test Flags Early DiseaseApril 13th, 2023
- ‘Game-Changing’ New Parkinson’s Test Paves Way for Treatments and CureApril 12th, 2023
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Yale-New Haven HospitalNew Haven, Connecticut